Advances 2022

Friday, May 20th 2022 at 12:00 pm EDT

Speaker: 

 
Michael G. Sension, MD
Medical Director
CAN Community Health
Fort Lauderdale, FL

Mike

   
  
     
Scoll down to access the program LOG-IN window at the bottom of this page!
 

Target Audience

This activity is intended for physicians, physician assistants, advanced practice nurses, general practitioners and other health care professionals involved in the treatment and management of patients who have or are at risk of HIV infection.

 

Learning Objectives

Upon completion of theactivity, participants should be better able to: 

• Apply current and emerging data on HIV therapies and treatment paradigms to improve the treatment of HIV-positive patients

• Describe and reduce side effects from ARVs that can interfere with adherence to ARV regimens

• Review and apply in a clinical setting information about new paradigms and approaches to treating and managing HIV, including two-drug ARV combinations

• Apply new and emerging information on long-acting ARVs to their clinical practice

• Discuss future directions in HIV treatment and HIV cure research  

 

Joint Accreditation Statement:

Jointly-Accredited-Provider-TM_1000x636  In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and ViralEd, Inc. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


Physician Continuing Medical Education:

The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Disclosure of Conflicts of Interest 

Postgraduate Institute for Medicine (PIM) requires faculty, planners and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

 

Michael G. Sension, MD

 

  • Fees for Non-CME/CE Services Received Directly from a Commercial Interest: Gilead, Janssen, Viiv.

 

Postgraduate Institute for Medicine

The PIM planners and others have nothing to disclose.  The ViralEd, Inc. planners and others have nothing to disclose.  

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

 

 

FILL OUT THE FORM BELOW TO JOIN OUR PROGRAM

 

Advances in Antiretroviral Therapy: Therapies and Strategies that are Changing Paradigms in 2022
Your name *
Email address *
Degree/Profession *
Country *
How many participants are watching using your internet connection? *
 
* Required